{rfName}
Ch

License and use

Icono OpenAccess

Altmetrics

Analysis of institutional authors

Alonso, TamaraAuthorAncochea Bermudez, JulioAuthorBautista Soriano, JoanAuthor

Share

May 8, 2020
Publications
>
Article

Chronic obstructive pulmonary disease (COPD) in Spain and the different aspects of its social impact: a multidisciplinary opinion document

Publicated to:Revista Espanola de Quimioterapia. 33 (1): 49-67 - 2020-02-01 33(1), DOI: 10.37201/req/2064.2019

Authors: Bouza, Emilio; Alvar, Agusti; Almagro, Pere; Alonso, Tamara; Ancochea, Julio; Barbe, Ferran; Corbella, Josep; Gracia, Diego; Mascaros, Enrique; Melis, Joan; Miravitlles, Marc; Pastor, Mariano; Perez, Patricia; Rudilla, David; Torres, Antoni; Bautista Soriano, Joan; Vallano, Antoni; Vargas, Franciso; Palomo, Esteban

Affiliations

Asociacien Alfa 1, Burgos, Spain - Author
Catalan Hlth Serv CatSalut, Barcelona, Spain - Author
CIBER Enfermedades Resp CIBERES CB06 06 0058, Madrid, Spain - Author
Ctr Salud Fuente San Luis, Hosp Dr Peset Specialist Family & Community Med, Dept Family & Community Med, Valencia, Spain - Author
Estrategia Epos Sistema Nacl Salud, Madrid, Spain - Author
Fdn Ciencias Salud, C Severe Ochoa 2, Madrid 28760, Spain - Author
Hosp Clin Barcelona, Inst Clin Resp, Barcelona, Spain - Author
Hosp Univ Mutua Terrassa, Chron Patients Unit, Barcelona, Spain - Author
Hosp Univ Vall dHebron, Dept Peumol, VHIR, Barcelona, Spain - Author
Inst Recerca Biomed Lleida, Lleida, Spain - Author
Minist Sanidad Consumo & Bienestar Social, Direcc Gen Salud Publ Calidad & Innovac, Subdirecc Gen Calidad & Innovac, Madrid, Spain - Author
Patient Care Air Liquide Healthcare, Madrid, Spain - Author
Univ Autonoma Madrid, Dept Med, Madrid, Spain - Author
Univ Autonoma Madrid, Hosp Princesa, Madrid, Spain - Author
Univ Autonoma Madrid, Pneumol Dept, Hosp Princesa, Madrid, Spain - Author
Univ Barcelona IDIBAPS, Resp Inst, Hosp Clin, Barcelona, Spain - Author
Univ Barcelona, Dept Pathol & Expt Therapeut, Barcelona, Spain - Author
Univ Barcelona, Serv Pneumol, Hosp Clin, IDIBAPS,CIBERES, Barcelona, Spain - Author
Univ Complutense Madrid, Fdn Ciencias Salud, Dept Prevent & Publ Hlth, Sch Med, Madrid, Spain - Author
Univ Complutense Madrid, Inst Invest Sanitaria Gregorio Maranon, Fdn Ciencias Salud,Dept Clin Microbiol & Infect D, Hosp Gen Univ Gregorio Maranon,Med Dept,Sch Med, Madrid, Spain - Author
Vanguardia, Barcelona, Spain - Author
‎ Asociacien Alfa 1, Burgos, Spain - Author
‎ Catalan Hlth Serv CatSalut, Barcelona, Spain - Author
‎ CIBER Enfermedades Resp CIBERES CB06 06 0058, Madrid, Spain - Author
‎ Ctr Salud Fuente San Luis, Hosp Dr Peset Specialist Family & Community Med, Dept Family & Community Med, Valencia, Spain - Author
‎ Estrategia Epos Sistema Nacl Salud, Madrid, Spain - Author
‎ Fdn Ciencias Salud, C Severe Ochoa 2, Madrid 28760, Spain - Author
‎ Hosp Clin Barcelona, Inst Clin Resp, Barcelona, Spain - Author
‎ Hosp Univ Mutua Terrassa, Chron Patients Unit, Barcelona, Spain - Author
‎ Hosp Univ Vall dHebron, Dept Peumol, VHIR, Barcelona, Spain - Author
‎ Inst Recerca Biomed Lleida, Lleida, Spain - Author
‎ Minist Sanidad Consumo & Bienestar Social, Direcc Gen Salud Publ Calidad & Innovac, Subdirecc Gen Calidad & Innovac, Madrid, Spain - Author
‎ Patient Care Air Liquide Healthcare, Madrid, Spain - Author
‎ Univ Autonoma Madrid, Dept Med, Madrid, Spain - Author
‎ Univ Autonoma Madrid, Hosp Princesa, Madrid, Spain - Author
‎ Univ Autonoma Madrid, Pneumol Dept, Hosp Princesa, Madrid, Spain - Author
‎ Univ Barcelona IDIBAPS, Resp Inst, Hosp Clin, Barcelona, Spain - Author
‎ Univ Barcelona, Dept Pathol & Expt Therapeut, Barcelona, Spain - Author
‎ Univ Barcelona, Serv Pneumol, Hosp Clin, IDIBAPS,CIBERES, Barcelona, Spain - Author
‎ Univ Complutense Madrid, Fdn Ciencias Salud, Dept Prevent & Publ Hlth, Sch Med, Madrid, Spain - Author
‎ Univ Complutense Madrid, Inst Invest Sanitaria Gregorio Maranon, Fdn Ciencias Salud,Dept Clin Microbiol & Infect D, Hosp Gen Univ Gregorio Maranon,Med Dept,Sch Med, Madrid, Spain - Author
‎ Vanguardia, Barcelona, Spain - Author
See more

Abstract

Chronic obstructive pulmonary disease (COPD) is one of the most prevalent diseases in the World, and one of the most important causes of mortality and morbidity. In adults 40 years and older, it affects more than 10% of the population and has enormous personal, family and social burden. Tobacco smoking is its main cause, but not the only one, and there is probably a genetic predisposition that increases the risk in some patients. The paradigm of this disease is changing in Spain, with an increase of women that has occurred in recent years. Many of the physio pathological mechanisms of this condition are well known, but the psychological alterations to which it leads, the impact of COPD on relatives and caregivers, the limitation of daily life observed in these patients, and the economic and societal burden that they represent for the health system, are not so well-known. A major problem is the high under-diagnosis, mainly due to difficulties for obtaining, in a systematic way, spirometries in hospitals and health-care centers. For this reason, the Fundación de Ciencias de la Salud and the Spanish National Network Center for Research in Respiratory Diseases (CIBERES) have brought together experts in COPD, patients and their organizations, clinical psychologists, experts in health economics, nurses and journalists to obtain their opinion about COPD in Spain. They also discussed the scientific bibliometrics on COPD that is being carried out from the CIBERES and speculated on the future of this condition. The format of the meeting consisted in the discussion of a series of questions that were addressed by different speakers and discussed until a consensus conclusion was reached.©The Author 2020. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).

Keywords

chronic obstructive pulmonary diseasehealth economicshealth-care burdenpatients organizationspsychological impactresearch bibliometricsAdjusted life yearsBiomass smokeChronic obstructive pulmonary diseaseCopdGender-differencesGlobal burdenHealthHealth economicsHealth-care burdenLung-functionOf-lifePatients organizationsPharmacological-treatmentPrimary-carePsychological impactResearch bibliometricsSpirometrySystematic analysis

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Revista Espanola de Quimioterapia, and although the journal is classified in the quartile Q4 (Agencia WoS (JCR)), its regional focus and specialization in Microbiology, give it significant recognition in a specific niche of scientific knowledge at an international level.

From a relative perspective, and based on the normalized impact indicator calculated from World Citations from Scopus Elsevier, it yields a value for the Field-Weighted Citation Impact from the Scopus agency: 1.01, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: ESI Nov 14, 2024)

This information is reinforced by other indicators of the same type, which, although dynamic over time and dependent on the set of average global citations at the time of their calculation, consistently position the work at some point among the top 50% most cited in its field:

  • Field Citation Ratio (FCR) from Dimensions: 4.9 (source consulted: Dimensions Aug 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-08-08, the following number of citations:

  • WoS: 13
  • Scopus: 14
  • Europe PMC: 9

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-08-08:

  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 220 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

    It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

    • The work has been submitted to a journal whose editorial policy allows open Open Access publication.
    • Additionally, the work has been submitted to a journal classified as Diamond in relation to this type of editorial policy.

    Leadership analysis of institutional authors

    This work has been carried out with international collaboration, specifically with researchers from: France.